92 related articles for article (PubMed ID: 12926049)
21. 2-Methoxyestradiol blocks cell-cycle progression at the G2/M phase and induces apoptosis in human acute T lymphoblastic leukemia CEM cells.
Zhang X; Huang H; Xu Z; Zhan R
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):615-22. PubMed ID: 20732853
[TBL] [Abstract][Full Text] [Related]
22. Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines.
Chaouchi N; Arvanitakis L; Auffredou MT; Blanchard DA; Vazquez A; Sharma S
Oncogene; 1995 Oct; 11(8):1615-22. PubMed ID: 7478586
[TBL] [Abstract][Full Text] [Related]
23. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.
Sharp NA; Luscombe MJ; Clemens MJ
Oncogene; 1989 Aug; 4(8):1043-6. PubMed ID: 2548145
[TBL] [Abstract][Full Text] [Related]
24. Novel lymphocyte growth-inhibiting tripeptide: N-acetyl-glu-ser-GlyNH(2).
Liu Y; Elgjo K; Wright M; Reichelt KL
Biochem Biophys Res Commun; 2000 Nov; 277(3):562-7. PubMed ID: 11061994
[TBL] [Abstract][Full Text] [Related]
25. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
[TBL] [Abstract][Full Text] [Related]
26. Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM.
Lin CK; Nguyen TT; Morgan TL; Mei RL; Kaptein JS; Kalunta CI; Yen CF; Park E; Zou HY; Lad PM
Exp Cell Res; 1998 Oct; 244(1):1-13. PubMed ID: 9770343
[TBL] [Abstract][Full Text] [Related]
27. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells.
Traganos F; Ardelt B; Halko N; Bruno S; Darzynkiewicz Z
Cancer Res; 1992 Nov; 52(22):6200-8. PubMed ID: 1330289
[TBL] [Abstract][Full Text] [Related]
28. Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events.
Wang H; Rubin M; Fenig E; DeBlasio A; Mendelsohn J; Yahalom J; Wieder R
Cancer Res; 1997 May; 57(9):1750-7. PubMed ID: 9135019
[TBL] [Abstract][Full Text] [Related]
29. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.
Vikhanskaya F; Erba E; D'Incalci M; Broggini M
Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577
[TBL] [Abstract][Full Text] [Related]
30. Oligosaccharides from human milk induce growth arrest via G2/M by influencing growth-related cell cycle genes in intestinal epithelial cells.
Kuntz S; Kunz C; Rudloff S
Br J Nutr; 2009 May; 101(9):1306-15. PubMed ID: 19079835
[TBL] [Abstract][Full Text] [Related]
31. Temporal patterns of gene expression of G1-S cyclins and cdks during the first and second mitotic cell cycles in mouse embryos.
Moore GD; Ayabe T; Kopf GS; Schultz RM
Mol Reprod Dev; 1996 Nov; 45(3):264-75. PubMed ID: 8916036
[TBL] [Abstract][Full Text] [Related]
32. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY
Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458
[TBL] [Abstract][Full Text] [Related]
33. Effect of staurosporine on MOLT-4 cell progression through G2 and on cytokinesis.
Traganos F; Gong J; Ardelt B; Darzynkiewicz Z
J Cell Physiol; 1994 Mar; 158(3):535-44. PubMed ID: 8126077
[TBL] [Abstract][Full Text] [Related]
34. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
[TBL] [Abstract][Full Text] [Related]
35. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.
Fribourg AF; Knudsen KE; Strobeck MW; Lindhorst CM; Knudsen ES
Cell Growth Differ; 2000 Jul; 11(7):361-72. PubMed ID: 10939590
[TBL] [Abstract][Full Text] [Related]
36. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells.
Arvanitakis L; Yaseen N; Sharma S
J Immunol; 1995 Aug; 155(3):1047-56. PubMed ID: 7636179
[TBL] [Abstract][Full Text] [Related]
37. Expression of c-fos and c-myc in Raji Burkitt's lymphoma cells during the progression of DMSO-induced G1 cells into S phase.
Teraoka H; Sawai M; Takase K; Yamamoto K; Nozaki N; Okazaki T; Tsukada K
Exp Cell Res; 1991 Jul; 195(1):274-6. PubMed ID: 1905238
[TBL] [Abstract][Full Text] [Related]
38. Cdk1 is a marker of proliferation in human lymphoid cells.
WoĊowiec D; Deviller P; Simonin D; Souchier C; Rimokh R; Benchaib M; Bryon PA; Ffrench M
Int J Cancer; 1995 May; 61(3):381-8. PubMed ID: 7729951
[TBL] [Abstract][Full Text] [Related]
39. c-Myc inhibition negatively impacts lymphoma growth.
Gomez-Curet I; Perkins RS; Bennett R; Feidler KL; Dunn SP; Krueger LJ
J Pediatr Surg; 2006 Jan; 41(1):207-11; discussion 207-11. PubMed ID: 16410134
[TBL] [Abstract][Full Text] [Related]
40. Hexamethylene bisacetamide inhibits malignant phenotype in T-ALL cell lines.
Cecchinato V; Erba E; Basile A; Scarpati B; Fazi C; Brando B; Comi P; Chiaramonte R
Leuk Res; 2008 May; 32(5):791-7. PubMed ID: 17964649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
